University Hospital Mainz, Germany
David M. G. Halpin
Royal Devon & Exeter Hospital, Exeter, UK
He trained at Oxford & St Thomas Hospital Medical School: completing a D.Phil. in the Department of Human Anatomy, Oxford, before finishing his clinical training at St Thomas. He completed his postgraduate training in respiratory medicine at the Brompton Hospital.
He is a Fellow of Royal College Physicians, Member British Thoracic Society, European Respiratory Society & American Thoracic Society.
He leads a busy clinical department, continues research in respiratory medicine & has published widely. He lectures frequently around the world on COPD. He is an Associate Editor of Thorax.
He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.
Since 2010 he has also been Respiratory Clinical Lead for the NHS in the South West.
University College Dublin, St. Vincent’s Hospital Group, Dublin, Ireland
WALTER MCNICHOLAS is Newman Clinical Research Professor at University College Dublin (UCD) and Consultant in Respiratory and Sleep Medicine at St. Vincent’s Hospital Group, Dublin. He is current President of the European Sleep Research Society (ESRS) and a former President of the European Respiratory Society (ERS). He is a medical graduate of UCD and undertook his postgraduate training in Respiratory and Sleep Medicine at the University of Toronto. Walter is a Research Fellow at the UCD Conway Research Institute and is part of a multidisciplinary research group based in St. Vincent’s and the Conway Institute, which collaborates with other groups within UCD and throughout Europe. His research interests range from human clinical to basic cell and molecular biology, and include the pathophysiology, treatment and outcomes of obstructive sleep apnoea syndrome (OSA), the cardiovascular and metabolic consequences of the disorder, basic cell and molecular mechanisms and consequences of intermittent hypoxia, in addition to sleep disturbances in COPD and other chronic respiratory disorders. He is also closely involved in the evaluation of novel ambulatory monitoring devices for sleep disorders and is active in public health policy around driving risk in patients with OSA and sleepiness. He has supervised many PhD and other Doctoral research students over the past 30 years in his research laboratory at UCD and St. Vincent’s.
Walter is a past Associate Editor of the European Respiratory Journal and has published over 230 full papers in International Peer-reviewed Journals (h-index: 49 in Web of Science; 65 in Google Scholar). He serves on the Editorial Boards of several International Respiratory and Sleep Journals and is Associate or Section Editor in four journals. Walter has held many Leadership positions in National and International organisations. In addition to his current role as President of the European Sleep Research Society, he was President of the European Respiratory Society in 2003-2004 and President of the European Board of Accreditation in Pneumology from 2010-2014. He chaired an EU-sponsored COST Action (B26) on Obstructive Sleep Apnoea (2005-2010), and recently chaired a Working Group established by the Transport and Mobility Directorate of the European Commission on Sleep Apnoea and Driving (2012-2013), which led to an official EU Directive on this topic, issued in June 2014, that is now mandatory throughout all EU member states.
University Hospital A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy
Dr. Richeldi was also the Founder and Director of the Center for Rare Lung Diseases at the same university. From November 2005 to November 2008 he was the Director of the School of Specialization in Respiratory Medicine of the University of Modena and Reggio Emilia. From November 2012 he was the Deputy Dean for Education of the Faculty of Medicine of the University of Modena and Reggio Emilia. He serves as associate editor for the European Respiratory Journal and is a member of the editorial board of the American Journal of Respiratory and Critical Care Medicine. He is a member of the Microbiology, Tuberculosis and Pulmonary Infections program committee of the American Thoracic Society (ATS). He has been part of the panels in charge of the production of the ATS-ERS guidelines on “Diagnosis of tuberculosis infection” and “Idiopathic pulmonary fibrosis” and is a member and reviewer of the Cochrane Collaboration. Dr. Richeldi is a member of the Fleischner Society and has published more than 100 peer-reviewed papers and contributed several chapters in scientific books.